Science Explorer Back to mapMap
Discussion
Researcher · Wills Eye Hospital · United States

Carol L. Shields

Carol L. Shields publishes mostly in Ophthalmology, Oncology and Radiology, Nuclear Medicine and Imaging, on topics such as Ocular Oncology and Treatments, Cutaneous Melanoma Detection and Management and Retinal Development and Disorders.

ORCID 0000-0002-3288-3632 OpenAlex
World rank
#293,182
of 7,710,434 ranked researchers
Rank in United States
#106,598
of 1,627,098
Works
1,779
Citations
58k
Citations per work
32.5
h-index
119
i10-index 817Top 0.1% in Ophthalmology
Carol L. Shields

What does Carol L. Shields research?

Carol L. Shields's work is mostly in Medicine (63%), Biochemistry, Genetics and Molecular Biology (6%).

Health Sciences: 1,114 works · 62.6% of their workMedicine: 1,114 works · 62.6% of their workOphthalmology: 697 works · 39.2% of their workOncology: 139 works · 7.8% of their workRadiology, Nuclear Medicine and Imaging: 112 works · 6.3% of their workPulmonary and Respiratory Medicine: 85 works · 4.8% of their workNeurology: 80 works · 4.5% of their workEverything else: 557 works · 31.3% of their workLife Sciences: 109 works · 6.1% of their workBiochemistry, Genetics and Molecular Biology: 109 works · 6.1% of their workMolecular Biology: 109 works · 6.1% of their workTHEIR WORKCarol L. Shields1,779works
Life Sciences6%Health Sciences63%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Health Sciences1,11462.6%
    1. Medicine1,11462.6%
  2. Everything else55731.3%
    1. Biochemistry, Genetics and Molecular Biology1096.1%
  1. 1Ophthalmology39% of their works
  2. 2Oncology8% of their works
  3. 3Radiology, Nuclear Medicine and Imaging6% of their works
  4. 4Molecular Biology6% of their works
  5. 5Pulmonary and Respiratory Medicine5% of their works
  6. 6Neurology4% of their works

Research topics

Which keywords describe Carol L. Shields's research?

The keywords of their largest research topics: Genetic Mutations, Retinoblastoma, Uveal Melanoma, Epidemiology, Macular Degeneration, Dermoscopy, Melanoma and Gene Therapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Genetic Mutations1,3792 topics
  2. Retinoblastoma1,2281 topic
  3. Uveal Melanoma1,2281 topic
  4. Epidemiology3452 topics
  5. Macular Degeneration3452 topics
  6. Dermoscopy2231 topic
  7. Melanoma2231 topic
  8. Gene Therapy1781 topic
  9. Retinitis Pigmentosa1781 topic
  10. Glaucoma1731 topic
  11. Intraocular Pressure1731 topic
  12. Macular Hole1721 topic
  13. Vitreoretinal Surgery1721 topic
  14. Diabetic Retinopathy1671 topic
  15. Retinal Pigment Epithelium1671 topic
  16. Microphthalmia1511 topic
  17. Ocular Development1511 topic
  18. Behçet's Disease1221 topic
  19. Uveitis1221 topic

Where does Carol L. Shields work?

Carol L. Shields's main affiliation in the publication record is Wills Eye Hospital, United States.

How many publications and citations does Carol L. Shields have?

OpenAlex counts 1,779 works and 57,739 citations for Carol L. Shields, an h-index of 119, ranking #293,182 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Carol L. Shields

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Carol L. Shields. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.